Speech-Language Pathologists' Use of Myofunctional Devices in Therapy Programs
| Autor: | Hollie-Ann Lee Shortland, Gwendalyn Webb, Anne E. Vertigan, Sally Hewat |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Perspectives of the ASHA Special Interest Groups. 7:2012-2026 |
| ISSN: | 2381-473X 2381-4764 |
| DOI: | 10.1044/2022_persp-22-00145 |
| Popis: | Purpose: This study aimed to explore the use of myofunctional devices (MDs) by speech-language pathologists (SLPs) to gain a better understanding of how SLPs are utilizing these in the treatment of their patients. Method: Eleven SLPs from four countries participated in semistructured interviews. The interview transcripts were analyzed using qualitative content analysis. Participants' responses were coded and categorized to identify key themes related to the use of MDs in therapy. Results: Five key themes, composed of 11 main categories and 54 subcategories, were identified. Themes highlighted variability in the use of MDs, including the type of device, application of the device, and dosage. Successful outcomes with the use of MDs were influenced by clinical experience and training, a multidisciplinary approach, along with client/family adherence to therapy. Participants frequently described the use of MDs as one component of an overall therapy program and reported on the need for further research to guide the use of MDs in speech-language pathology treatment. Conclusions: The use of MDs in speech-language pathology practice is often related to the expertise and experience of the SLP. Although SLPs report positive clinical outcomes, there remains a need for further research to support the use of MDs in therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|